Does colchicine work for CVD or doesn’t it? That’s the question the study authors hoped to answer, but there’s little ...

Market OverviewThe global Epilepsy Drugs Market is valued at USD 10.63 billion in 2024 and is projected to reach a value ...

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we ...

With clinical trials under pressure, industry leaders say it’s time for reform, digital transformation, and more patient-centric models.

Quest Diagnostics yesterday announced the launch of a new diagnostic test for Oropouche virus, a disease primarily spread by ...

HDE Surveillance Registry Data Captures Key Metrics for Future Analysis of QUELIMMUNE Performance DENVER, July (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage ...

Nicotine vaping continues to outperform FDA-approved smoking cessation therapies in well-designed studies, including a new clinical trial conducted in Australia. This growing body of evidence badly ...

Over thirty promising, young Utrecht researchers will receive a Veni grant of up to 320,000 euros from the Dutch Research Council (NWO). 1 in 7 Venis went to Utrecht researchers this year.

In a monthly zoonotic flu update, the World Health Organization (WHO) said Bangladesh and India have reported new H5N1 avian ...

New Data from PURPOSE Trials Further Demonstrate that Lenacapavir (Yeztugo®) was Effective and Well Tolerated Across a Broad Range of Populations, Including ...

URECE is a new therapeutic medicine for gout and hyperuricemia discovered by FUJI YAKUHIN. It suppresses uric acid reabsorption and lowers blood uric acid levels by selectively inhibiting the urate ...

Tocilizumab significantly reduced 28-day mortality and length of ICU stay in patients with severe COVID-19 pneumonia and low S-spike nAb titers.